Library
Gender differences in clinical registration trials: is there a real problem?
2 January 2018. doid: 10.1111/bcp.13497
Labots G, Jones A, de Visser SJ, Rissmann R, Burggraaf J
View publicationSeveral studies have reported the under-representation of women in clinical trials, thereby challenging the external validity of the benefit/risk assessments of launched drugs. Our aim was to determine the extent to which women have been included in clinical trials used for drug registration and to analyse the fraction of women participating in phases I, II and III.
Advancing the boundaries of clinical drug development
Wondering how we can help you? Reach out to us.
